Skip to main content
OpenTrials

Clinical trial condition

Digestive System Diseases

Explore clinical trials studying Digestive System Diseases. Study availability and eligibility vary by location and protocol.

305 public trials 54 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Diseases trial results

Completed

A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)

NCT03905330

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +4 more
Locations
  • Children's Hospital Los Angeles CHLA Los Angeles, California, United States
  • Medstar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Advent Health Orlando, Florida, United States
  • The Children's Hospital at Montefiore Yeshiva University - Montefiore Medical Center New York, United States
View all 31 locations
View Trial Details
Completed

A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma

NCT02993731

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Ductal, +12 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Clearview Cancer Institute (CCI) Huntsville, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
View all 267 locations
View Trial Details
Completed

A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer

NCT02753127

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +11 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
View all 211 locations
View Trial Details
Completed

Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols

NCT04299880

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +10 more
Locations
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Maine Center for Cancer Medicine Scarborough, Maine, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
  • Centre Antoine Lacassagne Nice, France
View Trial Details

Related conditions